Article information
Full text is only aviable in PDF
Bibliografía
[1.]
I. Izarzugaza Lizarraga.
El cáncer de pulmón en España Revisión epidemiológica.
Arch Bronconeumol, 28 (1992), pp. 311-319
[2.]
P. Cortina, J.L. Alfonso, C. Sáiz, A. Sabater, J.F. González.
Mortality trends of different localizations of cancer in Spain (1951–1987).
Europ J Cancer Prev, 2 (1993), pp. 181-183
[3.]
I. Casado Moreno, M. Martín Romero, R. Luque Márquez, M. Fernández Vivas, P. Rodríguez Benítez, P.I. Castillo Higueras.
Manejo diagnóstico del carcinoma broncogénico en un hospital de primer nivel.
Arch Bronconeumol, 29 (1993), pp. 117
[4.]
J.R. Hernández Hernández, M.A. Garcinuño, J.A. Tapias, J.M. Barragan, A.R. Puebla, T. Carmona, et al.
Estudio prospectivo sobre la epidemiología y aspectos clínicos del carcinoma broncopulmonar en la provincia de Ávila.
Años 1992 y 1993. Arch Bronconeumol, 30 (1994), pp. 65
[5.]
J. Sánchez Lloret, M. Mateú Navarro.
Tratamiento quirúrgico.
Cáncer de Pulmón. Monografías Clínicas de Oncología., pp. 46-62
[6.]
J. Padilla Alarcón, E. Blasco Armengod, J.M. Borro Maté, G. Galán Gil, F. París Romeu.
Factores pronósticos y supervivencia en el tratamiento quirúrgico del carcinoma broncopulmonar no anaplásico de células pequeñas en estadio I.
Arch Bronconeumol, 29 (1993), pp. 3-6
[7.]
J. Durán Cantolla, L. García Castrillo, J.J. González Macías, R. Aguero Balbin, M. Carbajo Carbajo, F.J. Ortega Morales, et al.
Estudio prospectivo multivariante sobre factores pronósticos en el carcinoma de pulmón no microcelular: resultados a 5 años.
Arch Bronconeumol, 30 (1994), pp. 124-130
[8.]
T. Naruke, T. Goya, R. Tsuchiya, K. Suemasu.
Prognosis and survival in resected lung carcinoma based on the new international staging system.
J Thorac Cardiovasc Surg, 96 (1988), pp. 440-447
[9.]
C.F. Mountain.
Value of the new TNM staging System for lung cancer.
Chest, 96 (1989), pp. 47-49
[10.]
H.C. Fernando, P. Goldstraw.
The accuracy of clinical evaluative intrathoracic staging in lung cancer as assessed by postsurgical pathologic staging.
Cancer, 65 (1990), pp. 2.503-2.506
[11.]
López Encuentra A. Clasificación anatómica del tumor y clasificación clínica del paciente. Decisiones individualizadas en situación clínica desfavorable. Ponencia “Abordaje multidisciplinario del tratamiento del cáncer de pulmón”. 1.° Congreso Luso-Español de Neumología. Lisboa, mayo. 1989.
[12.]
A. López Encuentra.
La clasificación TNM del carcinoma broncogénico, seis años después.
Arch Bronconeumol, 28 (1992), pp. 360-364
[13.]
C.F. Mountain.
A new international staging system for lung cancer.
Chest, 89 (1986), pp. 225-233
[14.]
A.R. Feinstein, D.M. Sosin, C.K. Wells.
The Will-Rogers phenomenon Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer.
N Engl J Med, 312 (1985), pp. 1.604-1.608
[15.]
H.M. Sandler, W.J. Curran, A.T. Turrissi.
The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage 1 non-small cell lung cancer.
Int J Radiat Oncol Biol Phys, 19 (1990), pp. 9-13
[16.]
J.A. Roth.
Advances in cellular and molecular biology of non-small cell lung cancer.
Lung Cancer., pp. 85-104
[17.]
A.R. Feinstein, C.K. Wells.
A clinical-severity staging system for patients with lung cancer.
Medicine, 69 (1990), pp. 1-33
[18.]
C. Ricci, E.A. Rendina, F. Venuta, R. Guerricchio.
Thoracic surgery in the elderly.
Perioperative Care. Current topics in general thoracic surgery: an international series, pp. 135-159
[19.]
T. Naruke.
Surgery of lung cancer Summaries of the lectures on clinical oncology.
Japan International Cooperation Agency, (1989), pp. 377-398
[20.]
R.J. Ginsberg, L.D. Hill, R.T. Eagan, P. Thomas, C.F. Mountain, J. Deslauriers, et al.
Modern thirty-day operative mortality for surgical resections in lung cancer.
J Thorac Cardiovasc Surg, 86 (1983), pp. 654-658
[21.]
P.S. Romano, D.H. Mark.
Patient and hospital characteristics related to in-hospital mortality after lung cancer resection.
Chest, 101 (1992), pp. 1.332-1.337
[22.]
J. Benichou, C.H. Fabre, C. Chastang, B. Lebeau, P. Babo, J.L. Rebishung, et al.
Facteurs pronostiques du cancer du poumon opéré non à petites cellules.
Rev Mal Resp, 4 (1987), pp. 301-309
[23.]
K.E. Staley.
Prognostic factors for survival in patients with inoperable lung cancer.
JNCI, 65 (1980), pp. 25-32
[24.]
R. Feld, R. Arriagada, D.L. Ball, K. Mattson, J.B. Sorensen.
Prognostic factors in non-small cell lung cancer: a consensus report.
Lung Cancer, 7 (1991), pp. 3-5
[25.]
E. Maki, R. Feld.
Prognostic factors in patients with non-small cell lung cancer. A critique of the world literature.
Lung Cáncer, 7 (1991), pp. 27-34
[26.]
G. Buccheri, D. Ferrigno.
Prognostic factors in lung cancer: tables and comments.
Eur Respir J, 7 (1994), pp. 1.350-1.364
[27.]
L.P. Fielding, D.E. Flenson.
Multiple prognostic factors and outcome analysis in patients with cancer Communication from American Joint Committee on Cáncer.
Cancer, 71 (1993), pp. 2.426-2.429
[28.]
American Joint Committee on Cancer.
Manual for staging of cáncer.
4.a, Lippincott Cia, (1992), pp. 115-122
[29.]
American Thoracic Society.
Clinical staging of primary lung cancer.
Am Rev Respir Dis, 127 (1983), pp. 659-664
[30.]
Grupo de Trabajo de, SEPAR., sobre carcinoma broncogénico.
Normativa sobre nomenclatura y clasificación del carcinoma broncogénico.
Ediciones Doyma SA, (1986),
[31.]
H. Tanaka, T. Hiayama, A. Hanai, I. Fujimoto.
Interhospital differences in cancer survivals in Japan The Research group for population-based cancer registration in Japan.
Jpn J Clin Oncol, 23 (1993), pp. 191-198
[32.]
P. Thomas, I. Sielezneff, J. Ragni, R. Giudicelli, P. Fuentes.
Is lung cancer resection justified in patients aged over 70 years?.
Eur J Cardiothorac Surg, 7 (1993), pp. 246-251
[33.]
C. Gebitakin, N.K. Gupta, P.G. Martin, N.R. Saunders, D.R. Walker.
Long-term results in the elderly following pulmonary resection for non-small cell lung carcinoma.
Eur J Cardiothorac Surg, 7 (1993), pp. 653-656
[34.]
G. Varela, J. Toledo.
Pulmonary resection for lung cancer in the elderly.
Perioperative Care. Current topics in general thoracic surgery: an international series, pp. 160-163
[35.]
J.L. Pater, M. Loeb.
Nonanatomic prognostic factors in carcinoma of the lung.
Cancer, 50 (1982), pp. 326-331
[36.]
M.H. Gail, R.T. Eagan, R. Feld, R. Ginsberg, B. Goodall, L. Hill, et al.
Prognostic factors in patients with resected stage I non-small cell lung cancer.
Cancer, 54 (1984), pp. 1.802-1.813
[37.]
J.B. Sorensen, J.H. Badsberg.
Prognostic factors in resected stages I and Il adenocarcinoma of the lung.
J Thorac Cardiovasc Surg, 99 (1990), pp. 218-226
[38.]
U. Pastorino, M. Valente, V. Bedini, A.M. Pagnoni, G. Ravasi.
Effect of chronic cardiopulmonary disease on survival after resection for stage la lung cancer.
Thorax, 37 (1982), pp. 680-683
[39.]
L.H. Kuller, J. Ockene, E. Meilann, K.H. Svendsen.
Relation of forced expiratory volume in one second (FEV1) to lung cancer mortality in the multiple risk factor intervention trial.
Am J Epidemiol, 132 (1990), pp. 265-274
[40.]
R.C. Read, G. Yoder, R.C. Schaeffer.
Survival after conservative resection for TI NOMO non-small cell lung cáncer.
Ann Thorac Surg, 49 (1990), pp. 391-400
[41.]
A. López Encuentra, A. De Pablo, M. Izquierdo Patrón, J. Castelao Naval, P. Martín Escribano.
Comorbilidad de carcinoma broncogénico, potencialmente resecable, y obstrucción crónica al flujo aéreo. Su significado clínico.
Arch Bronconeumol, 29 (1993), pp. 115
[42.]
W.A. Satariano, D.R. Ragland.
The effect of comorbidity on 3-years survival of women with primary breast cancer.
Ann Intern Med, 120 (1994), pp. 104-110
[43.]
A. Yellin, L.R. Hill, J.R. Benfield.
Bronchogenic carcinoma associated with upper aerodigestive cancers.
J Thorac Cardiovasc Surg, 91 (1986), pp. 674-683
[44.]
J. Moya, A. Arellano.
Dobles neoplasias de pulmón y laringe.
Arch Bronconeumol, 28 (1992), pp. 341-347
[45.]
P.A. Thomas, L. Rubinstein.
Malignant disease appearing late after operation for TINO non-small-cell lung cancer. The Lung Cáncer Study Group.
J Thorac Cardiovasc Surg, 106 (1993), pp. 1.053-1.058
[46.]
G. Massard, N. Roeslin, G.M. Jung, P. Dumont, J.M. Wihlm, G. Morand.
Bronchogenic cancer associated with head and neck tumors.
J Thorac Cardiovasc Surg, 106 (1993), pp. 218-227
[47.]
A. Rovirasa, J. Bellmunt, A. López, M. Fernández, M. Guerra, J. Montagut.
Incidencia de segundas neoplasias en el cáncer de laringe avanzado. Impacto sobre la supervivencia.
Med Clin (Barc), 102 (1994), pp. 121-124
[48.]
S. Andreani, U. Pastorino, M. Infante.
Second primary tumors in resected stage I lung cancer.
Lung Cancer, 11 (1994), pp. 167
[49.]
M.H. Criqui, R.D. Langer, A. Frover, A. Fronek, H.S. Feigelson, M.R. Klauber, et al.
Mortality over a period of 10 years in patients with peripheral arterial disease.
N Engl J Med, 326 (1992), pp. 381-386
[50.]
J. Estapé, M.C. Guzmán, A. Agustí.
Estudio comparativo del TNM clínico y del posquirúrgico en cáncer de pulmón no de células pequeñas. A propósito de 952 casos.
Neoplasia, 6 (1989), pp. 211-214
[51.]
I. Sánchez Hernández, L. Hernández Blasco, R. Roca Serrano, M. Jiménez, A. López Encuentra, J. Toledo.
Análisis de la eficacia de la clasificación tumoral anatómica pretoracotomía en el carcinoma broncogénico Comparación con la clasificación postoracotomía.
Arch Bronconeumol, 25 (1989), pp. 53
[52.]
F. Sebastián Quetglas, A. Paredes Lario, C. Sola Rocabert, A. Orube Bona, M. Sánchez Parra, I. Álvarez López.
Estudio comparativo entre estadio clínico y estadio patológico en una serie de 116 carcinomas pulmonares.
Arch Bronconeumol, 27 (1991), pp. 65-66
[53.]
H. Bülzebruck, P. Drings, K. Kayser, V. Schultz, S. Tvengerthal, I. Vogt-Moykopf.
Classification of lung cancer: first experiences with the new TNM classification.
Eur Respir J, 4 (1991), pp. 1.197-1.206
[54.]
P. Macchiarini, A.R. Chapelier, I. Monnet, J.M. Vannetzel, J.L. Rebishung, J. Cerrina, et al.
Extended operations after induction therapy for stage IIIb (T4) non-small cell lung cancer.
Ann Thorac Surg, 57 (1994), pp. 966-973
[55.]
R. Tsuchiya, Asamura El, H. Kondo, T. Goya, T. Naruke.
Extended resection of the left atrium, great vessels, or both for lung cancer.
Ann Thoracic Surg, 57 (1994), pp. 960-965
[56.]
R. Agüero, J. Durán, R. Ondiviela, F. Mazorra, J. Ortega, M. Carbajo, et al.
Discordancias anatomopatológicas entre los diagnósticos pre y posquirúrgicos en 150 enfermos intervenidos por carcinoma pulmonar.
Arch Bronconeumol, 25 (1989), pp. 54
[57.]
C.J. Álvarez Martínez, M.T. Sotelo, A. López Encuentra, R. Roca Serrano, M.T. Martínez Martínez, C. Melero, et al.
Exactitud del diagnóstico prequirúrgico de la estirpe tumoral en el carcinoma broncogénico.
Arch Bronconeumol, 27 (1991), pp. 62
[58.]
L.J. Kohman, J.A. Meyer, P.M. Ikins, R.P. Oates.
Random versus predictable risks of mortality after thoracotomy for lung cáncer.
J Thorac Cardiovasc Surg, 91 (1986), pp. 551-554
[59.]
J. Vansteenkiste, J. Weyler, A. Thibaut, G. Deneffe, M. Haelterman, J. van Meerbeeck, et al.
A hospital-based lung cancer registry in Flanders/Belgium: recent data and survival analysis on 2.709 patients.
Lung Cancer, 11 (1994), pp. 53
[60.]
G. Varela, R. Roca, M. Bogaert, E. Larrú, J. Toledo.
Toracotomía por carcinoma broncogénico en pacientes mayores de 70 años.
Arch Bronconeumol, 24 (1988), pp. 62-72
[61.]
J. Astudillo, C. Conill.
Resultados en el tratamiento quirúrgico del carcinoma broncogénico en pacientes mayores de 70 años.
Arch Bronconeumol, 26 (1990), pp. 297-300
[62.]
T. Osaki, T. Shirakusa, M. Kodate, R. Nakanishi, T. Mitsudomi, H. Veda.
Surgical treatment of lung cancer in the octogenarian.
Ann Thorac Surg, 57 (1994), pp. 188-193
[63.]
K. Vantogelen, N. Rotmensz, E. Van der Schveren.
Quality control of validity of data collected in clinical trials.
Eur J Cáncer Clin Oncol, 25 (1989), pp. 1.241-1.247
[64.]
C. Schaake-Koning, A. Kirkpatrick, R. Kroger, N. Van-Zandwijk, H. Bartelink.
The need for immediate monitoring of treatment parameters and uniform assessment of patient data in clinical trials. A quality control study of the EORTC radiotherapy and lung cancer cooperative groups.
Eur J Cáncer, 27 (1991), pp. 615-619
[65.]
R.B. Weiss, N.J. Vogelzang, B.A. Peterson, L.C. Panasci, J.T. Carpenter, M. Gavigan, et al.
A successful system of scientific data audits for clinical trials. A report from the cancer and leukemia group B.
JAMA, 270 (1993), pp. 495-496
[66.]
L. Ghandur-Mnaymneh, W.A. Raub, K.S. Sridhar, J. Albores-Saavedra, E. Gould, R.C. Duncan.
The accuracy of the histological classification of lung carcinoma and its reproductibility: a study of 75 archived cases of adenosquamous carcinoma.
Cancer Invest, 11 (1993), pp. 641-651
[67.]
R. Keehn, O. Auerbach, S. Nambu, D. Carter, Y. Shimosato, S.D. Greenberg, et al.
Reproductibility of major diagnoses in a binational study of lung cancer in uranium miners and atomic bomb survivors.
Am J Clin Pathol, 101 (1994), pp. 478-482
[68.]
Y. Ichinose, N. Hara, M. Ohta, T. Yano, K. Maeda, H. Asoh, et al.
Is T factor of the TNM staging system a predominant prognostic factor in pathologic stage I non-small cell lung cancer?.
J Thorac Cardiovasc Surg, 106 (1993), pp. 90-94
[69.]
P. Macchiarini, G. Fontanini, M.J. Hardin, F. Squartini, C.A. Angeletti.
Relation of neovascularisation to metastases of non-small cell lung cancer.
Lancet, 340 (1992), pp. 145-146
[71.]
A.F. Gazdar.
Molecular markers for the diagnosis and prognosis of lung cancer.
Cancer, 69 (1992), pp. 1.592-1.599
[72.]
R. Rosell, S. Li, Z. Skacel, J.L. Mate, J. Maestre, M. Canela, et al.
Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Oncogene, 8 (1993), pp. 2.407-2.412
[73.]
F. Pezzella, H. Turley, I. Kuzu, M.F. Tungekar, M.S. Dunniel, C.B. Pierce, et al.
bel-2 protein in non-small cell lung carcinoma.
N Engl J Med, 329 (1993), pp. 690-694
[74.]
M. Carbajo, F.J. Ortega, M. Hernández.
Epidermoid carcinoma of the lung in stage I: factors of prognostic interest.
Histol Histopathol, 8 (1993), pp. 41-45
[75.]
M. Díaz, A. Torres, M.D. Ortega, M.L. Maestro, A. Gómez, A. Cidoncha, et al.
Determinación de marcadores tumorales séricos (CEA SCC y CA 125) en pacientes con cáncer de pulmón. I Análisis pretratamiento.
Arch Bronconeumol, 29 (1993), pp. 22-26
[76.]
D. Ferrigno, G. Buccheri, A. Biggi.
Serum tumor markers in lung cancer: history, biology and clinical applications.
Eur Respir J, 7 (1994), pp. 186-197
[77.]
M. Díaz, A. Torres, M. Pollan.
Prognostic significance of serum CA 125 antigen assay in patients with non-small cell lung cancer.
Cancer, 73 (1994), pp. 1.368-1.376
Coordinadores del GCCB-S: J.L. Duque Medina (Hospital Clínico Universitario. Valladolid), A. López Encuentra (Hospital Universitario 12 de Octubre. Madrid).
EI GCCB-S ha recibido ayudas de la Sociedad Española de Neumologia y Cirugía Torácica (SEPAR), de la Consejería de Salud y Bienestar Social de la Junta de Castilla-León y de la Fundación Menarini.
Copyright © 1995. Sociedad Española de Neumología y Cirugía Torácica
Publish in
Archivos de Bronconeumología
Free access articles
10.1016/j.arbres.2024.09.011
10.1016/j.arbres.2024.09.015
Arch Bronconeumol. 2024;60:539-40
Graphical abstract
Archivos de Bronconeumología is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.
Archivos de Bronconeumología follows the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals